Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the relative bioavailability of UHAC 62 XX capsule and two different
tablet formulations (TF1 and TF2), and to obtain data for rational design of a subsequent
pivotal bioequivalence (BE) study between capsule and tablet formulations.